These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1496945

  • 1. Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
    Arguedas AG, Stutman HR, Zaleska M, Knupp CA, Marks MI, Nussbaum E.
    Am J Dis Child; 1992 Jul; 146(7):797-802. PubMed ID: 1496945
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE, Prince RA, Seilheimer DK, Bosso JA.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of cefepime in patients with respiratory tract infections.
    Kovarik JM, ter Maaten JC, Rademaker CM, Deenstra M, Hoepelman IM, Hart HC, Matzke GR, Verhoef J.
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1885-8. PubMed ID: 2291655
    [Abstract] [Full Text] [Related]

  • 4. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 5. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
    Cahen P, Le Bourgeois M, Delacourt C, Coustère C, Nicaise P, de Blic J, Véron M, Scheinmann P, Gaillard JL.
    Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P, Ategbo S, Turck D, Husson MO, Launay V, Loeuille GA, Sardet A, Deschildre A, Druon D, Arrouet-Lagande C.
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [Abstract] [Full Text] [Related]

  • 7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009528. PubMed ID: 23152277
    [Abstract] [Full Text] [Related]

  • 8. Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa.
    Tam VH, Louie A, Lomaestro BM, Drusano GL.
    Pharmacotherapy; 2003 Mar 14; 23(3):291-5. PubMed ID: 12627925
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis.
    Autry EB, Rybak JM, Leung NR, Gardner BM, Burgess DR, Anstead MI, Kuhn RJ.
    Pharmacotherapy; 2016 Jan 14; 36(1):13-8. PubMed ID: 26748559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cefepime pharmacokinetics in cystic fibrosis.
    Hamelin BA, Moore N, Knupp CA, Ruel M, Vallée F, LeBel M.
    Pharmacotherapy; 1993 Jan 14; 13(5):465-70. PubMed ID: 8247913
    [Abstract] [Full Text] [Related]

  • 14. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B, Malmborg AS, Alfredson H, Ericsson A.
    J Antimicrob Chemother; 1983 Jul 14; 12 Suppl A():283-7. PubMed ID: 6352633
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD, Yamashita TS, Knupp CK, Veazey JM, Blumer JL.
    Antimicrob Agents Chemother; 1997 Aug 14; 41(8):1783-7. PubMed ID: 9257761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis.
    Hjelte L, Malmborg AS, Strandvik B.
    J Antimicrob Chemother; 1989 Jun 14; 23(6):885-90. PubMed ID: 2503488
    [Abstract] [Full Text] [Related]

  • 20. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S, Zielen S.
    Paediatr Drugs; 2005 Jun 14; 7(6):353-63. PubMed ID: 16356023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.